SPARC (Secreted Protein Acidic and Rich in Cysteine), also known as osteonectin or BM-40, is a 303-amino acid matricellular glycoprotein that modulates cell-matrix interactions rather than providing direct structural support. SPARC exhibits modular architecture comprising an acidic N-terminal domain (Ca2+ binding), a central follistatin-like domain with a Kazal-like protease inhibitor motif, and a C-terminal extracellular calcium-binding (EC) domain containing two EF-hand motifs. The protein binds 8-10 Ca2+ ions per molecule with both high-affinity (EF-hand) and low-affinity (acidic domain) sites. SPARC is a high-affinity collagen-binding protein with sequence-specific recognition of the GVMGFO motif in collagens I, IV, and V. Its primary biological role is as a counter-adhesive factor that disrupts focal adhesions and promotes cell rounding/deadhesion, paradoxically regulating cell-matrix interactions through context-dependent effects on cell adhesion, migration, and ECM assembly. SPARC also functions in regulating angiogenesis (both pro- and anti-angiogenic depending on context), bone mineralization by linking hydroxyapatite to collagen, and tissue remodeling during wound healing and development. The protein is highly expressed in tissues undergoing morphogenesis, remodeling, and repair. Recessive mutations in SPARC cause osteogenesis imperfecta type 17 (OI17), highlighting its essential role in collagen secretion and bone matrix organization.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0031012
extracellular matrix
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Core localization supported by phylogenetic inference and extensive experimental evidence.
Reason: SPARC is definitively localized to the extracellular matrix where it functions as a matricellular protein. This is a core cellular component annotation supported by phylogenetic analysis and consistent with its biological role in modulating ECM assembly and cell-matrix interactions.
|
|
GO:0005615
extracellular space
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: General extracellular localization supported by phylogenetic analysis and experimental data.
Reason: SPARC is a secreted protein that functions in the extracellular space. This broader localization term is appropriate and consistent with SPARC being found in extracellular matrix, basement membrane, and extracellular fluids.
|
|
GO:0048752
semicircular canal morphogenesis
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: Phylogenetically-inferred role in inner ear development.
Reason: This IBA annotation suggests a role in semicircular canal morphogenesis based on phylogenetic inference. While SPARC is expressed during development and tissue morphogenesis, this represents a specific developmental process rather than SPARC's core matricellular function. SPARC's role here would likely be as a modulator of ECM assembly during ear development.
|
|
GO:0050807
regulation of synapse organization
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: Phylogenetically-inferred role in synapse organization.
Reason: This IBA annotation suggests a role in regulating synapse organization based on phylogenetic inference. SPARC's counter-adhesive and ECM-modulating functions could plausibly affect synapse structure, but this is not a core biological process for SPARC and would be context-specific rather than central to its primary matricellular functions.
|
|
GO:0005509
calcium ion binding
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Core molecular function of SPARC supported by phylogenetic inference, direct biochemical evidence, and structural studies showing multiple Ca2+ binding sites.
Reason: SPARC is definitively a high-affinity calcium-binding protein with 8-10 Ca2+ binding sites per molecule. The acidic N-terminal domain binds 5-8 Ca2+ with low affinity, and the C-terminal EF-hand domain binds Ca2+ with high affinity. This is a core molecular function essential for protein structure and function.
Supporting Evidence:
PMID:7034958
Osteonectin is a 32,000 dalton bone-specific protein that binds selectively to both hydroxyapatite and collagen. When osteonectin is bound to insolubilized type I collagen, the resultant complex binds synthetic apatite crystals and free calcium ions.
PMID:9501084
The extracellular calcium-binding domain (positions 138-286) of the matrix protein BM-40 possesses a binding epitope of moderate affinity for several collagen types.
|
|
GO:0005509
calcium ion binding
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: Duplicate annotation via InterPro mapping, consistent with IBA and IDA evidence.
Reason: This IEA annotation based on InterPro domain recognition is consistent with the experimentally validated calcium binding function and can be retained as supporting evidence.
|
|
GO:0005604
basement membrane
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: Well-supported localization to basement membrane supported by UniProt subcellular location vocabulary and experimental studies.
Reason: SPARC is well-documented to localize in or around basement membranes, where it modulates ECM assembly and cell-matrix interactions. UniProt annotation states "In or around the basement membrane" based on multiple experimental studies.
|
|
GO:0005615
extracellular space
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: Duplicate annotation consistent with IBA evidence.
Reason: This IEA annotation from InterPro is consistent with experimental evidence and can be retained.
|
|
GO:0046872
metal ion binding
|
IEA
GO_REF:0000043 |
MODIFY |
Summary: Overly generic term when specific calcium ion binding is documented.
Reason: SPARC specifically binds calcium ions (GO:0005509), which is already well-annotated. The generic "metal ion binding" term is less informative than the specific calcium ion binding annotations. SPARC also binds copper ions, but the primary and most extensively studied metal binding activity is calcium.
Proposed replacements:
calcium ion binding
|
|
GO:0005515
protein binding
|
IPI
PMID:18808384 Identification of a novel protein promoting the colonization... |
REMOVE |
Summary: Non-informative generic annotation for interaction with bacterial protein FafA from Finegoldia magna.
Reason: The generic "protein binding" term provides no functional insight. This study identifies SPARC as a binding partner for a bacterial adhesin but does not inform our understanding of SPARC's core molecular functions. This appears to be an opportunistic interaction during bacterial infection rather than a core biological activity.
Supporting Evidence:
PMID:18808384
Epub 2008 Sep 18. Identification of a novel protein promoting the colonization and survival of Finegoldia magna, a bacterial commensal and opportunistic pathogen.
|
|
GO:0005515
protein binding
|
IPI
PMID:19011090 Structural basis of sequence-specific collagen recognition b... |
REMOVE |
Summary: Non-informative generic annotation from collagen binding study.
Reason: This study demonstrated collagen binding (already captured by GO:0005518), not a distinct protein binding function. The generic "protein binding" term adds no additional functional information beyond the specific collagen binding annotations.
Supporting Evidence:
PMID:19011090
Structural basis of sequence-specific collagen recognition by SPARC.
|
|
GO:0005515
protein binding
|
IPI
PMID:20926826 Interaction of recombinant myocilin with the matricellular p... |
REMOVE |
Summary: Non-informative generic annotation for interaction with myocilin.
Reason: While the SPARC-myocilin interaction may be relevant in glaucoma pathology, the generic "protein binding" term provides no functional insight. The study does not establish this as a core molecular function of SPARC.
Supporting Evidence:
PMID:20926826
Print 2011 Jan. Interaction of recombinant myocilin with the matricellular protein SPARC: functional implications.
|
|
GO:0005201
extracellular matrix structural constituent
|
RCA
PMID:28327460 Comprehensive proteomic characterization of stem cell-derive... |
REMOVE |
Summary: Mischaracterization of SPARC as a structural ECM component.
Reason: SPARC is definitively a matricellular protein, not a structural ECM component. Matricellular proteins modulate cell-matrix interactions and ECM assembly but do not themselves provide structural support. This annotation fundamentally misrepresents SPARC biology. The correct molecular function is as a regulatory/modulating protein, not as a structural constituent.
Supporting Evidence:
PMID:28327460
Epub 2017 Mar 7. Comprehensive proteomic characterization of stem cell-derived extracellular matrices.
|
|
GO:0031012
extracellular matrix
|
HDA
PMID:28327460 Comprehensive proteomic characterization of stem cell-derive... |
ACCEPT |
Summary: High-throughput proteomic identification of SPARC in ECM consistent with core localization.
Reason: This HDA annotation from a proteomic study of stem cell-derived ECM is consistent with the well-established ECM localization of SPARC.
Supporting Evidence:
PMID:28327460
Epub 2017 Mar 7. Comprehensive proteomic characterization of stem cell-derived extracellular matrices.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-9612277 |
ACCEPT |
Summary: Plasma membrane localization is supported by experimental evidence, though this specific citation may be from a pathway context.
Reason: While this Reactome annotation may have been derived from a pathway context, SPARC plasma membrane localization is supported by direct experimental evidence (IDA) showing localization to alpha-granule membranes, which are plasma membrane-derived.
|
|
GO:0005576
extracellular region
|
HDA
PMID:27068509 Extracellular matrix remodelling in response to venous hyper... |
ACCEPT |
Summary: High-throughput proteomic identification in varicose vein ECM.
Reason: This proteomic study of ECM remodeling in varicose veins identified SPARC, consistent with its core extracellular/ECM localization.
Supporting Evidence:
PMID:27068509
Apr 11. Extracellular matrix remodelling in response to venous hypertension: proteomics of human varicose veins.
|
|
GO:0001937
negative regulation of endothelial cell proliferation
|
IDA
PMID:12867428 Cleavage of the matricellular protein SPARC by matrix metall... |
ACCEPT |
Summary: Direct experimental evidence for SPARC peptides inhibiting endothelial cell proliferation.
Reason: This study demonstrated that MMP-3 cleavage of SPARC produces peptides (Z-2 and Z-3) that inhibit endothelial cell proliferation in a concentration-dependent manner. This anti-proliferative effect on endothelial cells is part of SPARC's anti-angiogenic activities and represents a core biological function.
Supporting Evidence:
PMID:12867428
In contrast, peptides Z-2 (6.1 kDa, containing Ca2+-binding EF hand-1) and Z-3 (2.2 kDa, containing neither Cu2+-binding motifs nor EF hands), inhibited cell proliferation in a concentration-dependent manner and exhibited no effects on vessel growth in the CAM.
|
|
GO:0005518
collagen binding
|
IDA
PMID:9501084 Crystal structure and mapping by site-directed mutagenesis o... |
ACCEPT |
Summary: Crystal structure and mutagenesis study definitively mapping the collagen-binding epitope in SPARC with sequence-specific recognition.
Reason: This is a definitive structural and functional study showing SPARC binds collagens I and IV with sequence-specific recognition of the GVMGFO motif. Five residues (R149, N156, L242, M245, E246) were identified as crucial for collagen binding. This represents a core molecular function of SPARC.
Supporting Evidence:
PMID:9501084
Five residues were crucial for binding, R149 and N156 in helix alphaA, and L242, M245 and E246 in a loop region connecting the two EF hands of BM-40. These residues are spatially close and form a flat ring of 15 A diameter which matches the diameter of a triple-helical collagen domain. The mutations showed similar effects on binding to collagens I and IV, indicating nearly identical binding sites on both collagens.
|
|
GO:0005737
cytoplasm
|
IDA
PMID:15389586 Spreading of embryologically distinct urothelial cells is in... |
KEEP AS NON CORE |
Summary: Experimental evidence for intracellular SPARC localization in cycling urothelial cells.
Reason: This study demonstrated that cycling urothelial cells sequester SPARC within cytoplasm and nuclei, while differentiated cells show apical membrane localization. While this is legitimate experimental evidence, cytoplasmic localization represents trafficking/biosynthetic localization rather than the functional location where SPARC exerts its core matricellular activities. SPARC is a secreted protein with an N-terminal signal peptide.
Supporting Evidence:
PMID:15389586
In contrast, the basal layer of transitional epithelium in vivo and cycling cells in vitro did not exhibit this apical staining pattern, but instead sequestered the SPARC polypeptide within urothelial cytoplasm and/or nuclei, as revealed by immunohistochemical analysis.
|
|
GO:0009986
cell surface
|
IDA
PMID:15389586 Spreading of embryologically distinct urothelial cells is in... |
ACCEPT |
Summary: Experimental evidence for SPARC localization at apical plasma membrane of differentiated urothelial cells.
Reason: This study showed polarized localization of SPARC to apical plasma membranes of suprabasal/intermediate urothelial cells. Cell surface localization is relevant for SPARC's counter-adhesive function and interaction with cell surface receptors, though the primary functional location is the extracellular matrix.
Supporting Evidence:
PMID:15389586
Through the use of a monoclonal antibody that recognizes this epitope, transitional epithelium was found to restrict expression of SPARC to the suprabasal and intermediate layer. Such intracellular expression was defined by immunoreactive signals that localized to the apical plasma membranes of suprabasal and intermediate cells.
|
|
GO:0010595
positive regulation of endothelial cell migration
|
IDA
PMID:12867428 Cleavage of the matricellular protein SPARC by matrix metall... |
ACCEPT |
Summary: SPARC-derived peptides stimulate endothelial cell migration in collagen gels.
Reason: This study showed that MMP-3-generated SPARC peptides Z-2 and Z-3 stimulated endothelial cell migration in collagen gels, demonstrating a pro-migratory effect. This represents part of SPARC's complex, context-dependent regulation of angiogenesis where different fragments have distinct activities.
Supporting Evidence:
PMID:12867428
Reciprocal results were obtained in a migration assay in native collagen gels: peptide Z-1 was ineffective over a range of concentrations, whereas Z-2 or Z-3 stimulated cell migration.
|
|
GO:0016363
nuclear matrix
|
IDA
PMID:15389586 Spreading of embryologically distinct urothelial cells is in... |
KEEP AS NON CORE |
Summary: Experimental evidence for SPARC in nuclear matrix, colocalized with Ki-67.
Reason: The study demonstrated SPARC presence in the nuclear matrix where it colocalized with Ki-67 antigen in cycling urothelial cells. However, this represents an atypical localization for a secreted matricellular protein. Nuclear localization may reflect biosynthetic/trafficking processes rather than core function. The functional significance remains unclear.
Supporting Evidence:
PMID:15389586
Elution of soluble proteins and DNA from urothelial cells revealed the presence of SPARC within the nuclear matrix--and that SPARC colocalized with the nuclear matrix Ki-67 antigen.
|
|
GO:0016525
negative regulation of angiogenesis
|
IDA
PMID:12867428 Cleavage of the matricellular protein SPARC by matrix metall... |
ACCEPT |
Summary: SPARC-derived peptides inhibit angiogenesis in vivo.
Reason: This study demonstrated that certain SPARC peptides (Z-2, Z-3) generated by MMP-3 cleavage inhibit angiogenesis, having no effect on vessel growth in the chick chorioallantoic membrane assay. This anti-angiogenic activity represents a core biological function of SPARC, though the protein shows context-dependent pro- and anti-angiogenic effects.
Supporting Evidence:
PMID:12867428
In contrast, peptides Z-2 (6.1 kDa, containing Ca2+-binding EF hand-1) and Z-3 (2.2 kDa, containing neither Cu2+-binding motifs nor EF hands), inhibited cell proliferation in a concentration-dependent manner and exhibited no effects on vessel growth in the CAM.
|
|
GO:0022604
regulation of cell morphogenesis
|
IDA
PMID:15389586 Spreading of embryologically distinct urothelial cells is in... |
ACCEPT |
Summary: SPARC inhibits cell spreading and promotes cell rounding in urothelial cells.
Reason: This study demonstrated that recombinant SPARC inhibits spreading of freshly plated urothelial cells in a concentration- and time-dependent manner (rounding assay). This counter-adhesive effect on cell morphology is a core biological function of SPARC as a matricellular protein that disrupts focal adhesions and regulates cell shape.
Supporting Evidence:
PMID:15389586
rSPARC activity was demonstrated and quantified with a rounding assay whereby the spreading of freshly plated cells was inhibited by recombinant SPARC in a concentration- and time-dependent manner. Inhibition of spreading was observed in urothelial cells derived from endoderm (bladder) and mesoderm (ureter) germ layers.
|
|
GO:0005509
calcium ion binding
|
IDA
PMID:7034958 Osteonectin, a bone-specific protein linking mineral to coll... |
ACCEPT |
Summary: Direct experimental demonstration of calcium binding by osteonectin in the seminal 1981 study.
Reason: This is the foundational experimental evidence for SPARC calcium binding activity. The study demonstrated that osteonectin binds free calcium ions and showed this is a core molecular function.
Supporting Evidence:
PMID:7034958
Osteonectin is a 32,000 dalton bone-specific protein that binds selectively to both hydroxyapatite and collagen. When osteonectin is bound to insolubilized type I collagen, the resultant complex binds synthetic apatite crystals and free calcium ions.
|
|
GO:0005518
collagen binding
|
IDA
PMID:7034958 Osteonectin, a bone-specific protein linking mineral to coll... |
ACCEPT |
Summary: Foundational experimental evidence demonstrating SPARC binds selectively to collagen type I.
Reason: This 1981 study provided the first experimental demonstration that osteonectin/SPARC binds selectively to type I collagen, establishing collagen binding as a core molecular function. When bound to collagen, the complex also binds calcium and nucleates mineral deposition.
Supporting Evidence:
PMID:7034958
Osteonectin is a 32,000 dalton bone-specific protein that binds selectively to both hydroxyapatite and collagen. When osteonectin is bound to insolubilized type I collagen, the resultant complex binds synthetic apatite crystals and free calcium ions.
|
|
GO:0005737
cytoplasm
|
IDA
PMID:11856645 Investigation of osteocalcin, osteonectin, and dentin sialop... |
KEEP AS NON CORE |
Summary: Cytoplasmic localization during biosynthesis in developing teeth.
Reason: This study on developing human teeth detected osteonectin/SPARC in cytoplasm, consistent with biosynthetic/secretory pathway localization. As a secreted protein, SPARC transits through the cytoplasm but this is not its functional location.
Supporting Evidence:
PMID:11856645
Investigation of osteocalcin, osteonectin, and dentin sialophosphoprotein in developing human teeth.
|
|
GO:0005737
cytoplasm
|
IDA
NOT
PMID:1737102 Localization of platelet osteonectin at the internal face of... |
ACCEPT |
Summary: PMID:1737102 localized platelet osteonectin to alpha-granule membranes rather than cytoplasm.
Reason: The study used immunogold labeling to localize osteonectin to the internal face of alpha-granule membranes, supporting a NOT cytoplasm annotation for this PMID.
Supporting Evidence:
PMID:1737102
Localization of platelet osteonectin at the internal face of the alpha-granule membranes in platelets and megakaryocytes.
|
|
GO:0005737
cytoplasm
|
IDA
PMID:3400777 Osteonectin/SPARC/BM-40 in human decidua and carcinoma, tiss... |
KEEP AS NON CORE |
Summary: Cytoplasmic staining in decidua and carcinoma tissues.
Reason: This immunolocalization study in decidua and carcinoma showed cytoplasmic staining, consistent with biosynthetic/secretory pathway localization for this secreted ECM protein. Not the primary functional location.
Supporting Evidence:
PMID:3400777
Osteonectin/SPARC/BM-40 in human decidua and carcinoma, tissues characterized by de novo formation of basement membrane.
|
|
GO:0005739
mitochondrion
|
IDA
NOT
PMID:1737102 Localization of platelet osteonectin at the internal face of... |
ACCEPT |
Summary: PMID:1737102 did not detect mitochondrial localization of platelet osteonectin.
Reason: This PMID reports alpha-granule membrane localization and supports a NOT mitochondrion annotation.
Supporting Evidence:
PMID:1737102
Localization of platelet osteonectin at the internal face of the alpha-granule membranes in platelets and megakaryocytes.
|
|
GO:0005886
plasma membrane
|
IDA
NOT
PMID:1737102 Localization of platelet osteonectin at the internal face of... |
ACCEPT |
Summary: PMID:1737102 localized osteonectin to alpha-granule membranes and did not report plasma membrane localization in resting platelets.
Reason: The abstract indicates internal alpha-granule membrane localization and a redistribution to the surface upon activation, so GOA captures this PMID as NOT plasma membrane.
Supporting Evidence:
PMID:1737102
Localization of platelet osteonectin at the internal face of the alpha-granule membranes in platelets and megakaryocytes.
|
|
GO:0009986
cell surface
|
IDA
PMID:3400777 Osteonectin/SPARC/BM-40 in human decidua and carcinoma, tiss... |
ACCEPT |
Summary: Cell surface localization in decidua and carcinoma tissues.
Reason: This immunolocalization study detected SPARC at cell surfaces in decidua and carcinoma. Cell surface localization is consistent with SPARC's counter-adhesive function and its ability to interact with cell surface receptors while also being deposited into the ECM.
Supporting Evidence:
PMID:3400777
Osteonectin/SPARC/BM-40 in human decidua and carcinoma, tissues characterized by de novo formation of basement membrane.
|
|
GO:0031091
platelet alpha granule
|
IDA
PMID:1737102 Localization of platelet osteonectin at the internal face of... |
ACCEPT |
Summary: Well-established localization of SPARC in platelet alpha granules.
Reason: SPARC is a well-documented component of platelet alpha granules, where it is stored and released upon platelet activation. This is an established biological function of SPARC in hemostasis and wound healing. The study specifically localized osteonectin to the internal face of alpha-granule membranes.
Supporting Evidence:
PMID:1737102
Localization of platelet osteonectin at the internal face of the alpha-granule membranes in platelets and megakaryocytes.
|
|
GO:0031092
platelet alpha granule membrane
|
IDA
PMID:1737102 Localization of platelet osteonectin at the internal face of... |
ACCEPT |
Summary: Specific localization to the internal face of platelet alpha granule membranes.
Reason: This study specifically demonstrated SPARC localization at the internal face of alpha-granule membranes in platelets and megakaryocytes, representing a more specific localization than just the alpha granule lumen. This is well-supported experimental evidence.
Supporting Evidence:
PMID:1737102
Localization of platelet osteonectin at the internal face of the alpha-granule membranes in platelets and megakaryocytes.
|
|
GO:0031093
platelet alpha granule lumen
|
TAS
Reactome:R-HSA-481007 |
ACCEPT |
Summary: Reactome pathway annotation for SPARC in platelet degranulation.
Reason: This Reactome annotation captures SPARC as a component released during platelet alpha granule exocytosis. This is consistent with experimental evidence showing SPARC in platelet alpha granules.
|
|
GO:0071682
endocytic vesicle lumen
|
TAS
Reactome:R-HSA-2247513 |
KEEP AS NON CORE |
Summary: Reactome annotation for SPARC uptake via STAB1-mediated endocytosis.
Reason: This Reactome pathway describes STAB1 (stabilin-1/FEEL-1)-mediated endocytosis of SPARC. While this represents a clearance mechanism for extracellular SPARC, endocytic vesicle localization is not a core functional location but rather represents protein turnover/degradation.
|
|
GO:0005576
extracellular region
|
TAS
Reactome:R-HSA-2197770 |
ACCEPT |
Summary: Reactome annotation for SPARC as STAB1 ligand.
Reason: This Reactome pathway describes SPARC binding to STAB1 receptor, consistent with SPARC's extracellular localization where it can interact with cell surface receptors.
|
|
GO:0005576
extracellular region
|
TAS
Reactome:R-HSA-2247513 |
ACCEPT |
Summary: Reactome annotation for STAB1-mediated endocytosis of extracellular SPARC.
Reason: Consistent with SPARC's extracellular localization prior to receptor-mediated endocytosis.
|
|
GO:0005576
extracellular region
|
TAS
Reactome:R-HSA-2424243 |
ACCEPT |
Summary: Reactome annotation for SPARC binding to collagen, hydroxylapatite, and Ca2+.
Reason: This Reactome pathway captures SPARC's core molecular interactions in the extracellular matrix, consistent with its matricellular function.
|
|
GO:0005576
extracellular region
|
TAS
Reactome:R-HSA-481007 |
ACCEPT |
Summary: Reactome annotation for SPARC release during platelet degranulation.
Reason: Consistent with SPARC being released into the extracellular region during platelet alpha granule exocytosis.
|
|
GO:0005515
protein binding
|
IPI
PMID:3402455 Complex formation of human thrombospondin with osteonectin. |
REMOVE |
Summary: Non-informative generic annotation for thrombospondin binding.
Reason: While SPARC forms complexes with thrombospondin in the ECM, the generic "protein binding" term provides no functional insight. The biological significance of this interaction is unclear and does not represent a core molecular function of SPARC.
Supporting Evidence:
PMID:3402455
Complex formation of human thrombospondin with osteonectin.
|
|
GO:0005576
extracellular region
|
NAS
PMID:14718574 The human plasma proteome: a nonredundant list developed by ... |
ACCEPT |
Summary: Non-traceable author statement identifying SPARC in human plasma proteome.
Reason: SPARC is a known component of the human plasma proteome, consistent with its secreted nature and presence in blood from platelet alpha granules. This represents extracellular localization.
Supporting Evidence:
PMID:14718574
Epub 2004 Jan 12. The human plasma proteome: a nonredundant list developed by combination of four separate sources.
|
|
GO:0050839
cell adhesion molecule binding
|
NAS | NEW |
Summary: Added to align core_functions with existing annotations.
Reason: Core function term not present in existing_annotations.
Supporting Evidence:
PMID:15389586
rSPARC activity was demonstrated and quantified with a rounding assay whereby the spreading of freshly plated cells was inhibited by recombinant SPARC in a concentration- and time-dependent manner.
|
id: P09486
gene_symbol: SPARC
product_type: PROTEIN
status: COMPLETE
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: 'SPARC (Secreted Protein Acidic and Rich in Cysteine), also known as
osteonectin or BM-40, is a 303-amino acid matricellular glycoprotein that modulates
cell-matrix interactions rather than providing direct structural support. SPARC
exhibits modular architecture comprising an acidic N-terminal domain (Ca2+ binding),
a central follistatin-like domain with a Kazal-like protease inhibitor motif, and
a C-terminal extracellular calcium-binding (EC) domain containing two EF-hand motifs.
The protein binds 8-10 Ca2+ ions per molecule with both high-affinity (EF-hand)
and low-affinity (acidic domain) sites. SPARC is a high-affinity collagen-binding
protein with sequence-specific recognition of the GVMGFO motif in collagens I, IV,
and V. Its primary biological role is as a counter-adhesive factor that disrupts
focal adhesions and promotes cell rounding/deadhesion, paradoxically regulating
cell-matrix interactions through context-dependent effects on cell adhesion, migration,
and ECM assembly. SPARC also functions in regulating angiogenesis (both pro- and
anti-angiogenic depending on context), bone mineralization by linking hydroxyapatite
to collagen, and tissue remodeling during wound healing and development. The protein
is highly expressed in tissues undergoing morphogenesis, remodeling, and repair.
Recessive mutations in SPARC cause osteogenesis imperfecta type 17 (OI17), highlighting
its essential role in collagen secretion and bone matrix organization.'
existing_annotations:
- term:
id: GO:0031012
label: extracellular matrix
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: Core localization supported by phylogenetic inference and extensive
experimental evidence.
action: ACCEPT
reason: SPARC is definitively localized to the extracellular matrix where it
functions as a matricellular protein. This is a core cellular component
annotation supported by phylogenetic analysis and consistent with its
biological role in modulating ECM assembly and cell-matrix interactions.
- term:
id: GO:0005615
label: extracellular space
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: General extracellular localization supported by phylogenetic
analysis and experimental data.
action: ACCEPT
reason: SPARC is a secreted protein that functions in the extracellular
space. This broader localization term is appropriate and consistent with
SPARC being found in extracellular matrix, basement membrane, and
extracellular fluids.
- term:
id: GO:0048752
label: semicircular canal morphogenesis
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: Phylogenetically-inferred role in inner ear development.
action: KEEP_AS_NON_CORE
reason: This IBA annotation suggests a role in semicircular canal
morphogenesis based on phylogenetic inference. While SPARC is expressed
during development and tissue morphogenesis, this represents a specific
developmental process rather than SPARC's core matricellular function.
SPARC's role here would likely be as a modulator of ECM assembly during
ear development.
- term:
id: GO:0050807
label: regulation of synapse organization
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: Phylogenetically-inferred role in synapse organization.
action: KEEP_AS_NON_CORE
reason: This IBA annotation suggests a role in regulating synapse
organization based on phylogenetic inference. SPARC's counter-adhesive and
ECM-modulating functions could plausibly affect synapse structure, but
this is not a core biological process for SPARC and would be
context-specific rather than central to its primary matricellular
functions.
- term:
id: GO:0005509
label: calcium ion binding
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: Core molecular function of SPARC supported by phylogenetic
inference, direct biochemical evidence, and structural studies showing
multiple Ca2+ binding sites.
action: ACCEPT
reason: SPARC is definitively a high-affinity calcium-binding protein with
8-10 Ca2+ binding sites per molecule. The acidic N-terminal domain binds
5-8 Ca2+ with low affinity, and the C-terminal EF-hand domain binds Ca2+
with high affinity. This is a core molecular function essential for
protein structure and function.
supported_by:
- reference_id: PMID:7034958
supporting_text: "Osteonectin is a 32,000 dalton bone-specific protein that
binds selectively to both hydroxyapatite and collagen. When osteonectin is
bound to insolubilized type I collagen, the resultant complex binds synthetic
apatite crystals and free calcium ions."
- reference_id: PMID:9501084
supporting_text: "The extracellular calcium-binding domain (positions 138-286)
of the matrix protein BM-40 possesses a binding epitope of moderate affinity
for several collagen types."
- term:
id: GO:0005509
label: calcium ion binding
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: Duplicate annotation via InterPro mapping, consistent with IBA and
IDA evidence.
action: ACCEPT
reason: This IEA annotation based on InterPro domain recognition is
consistent with the experimentally validated calcium binding function and
can be retained as supporting evidence.
- term:
id: GO:0005604
label: basement membrane
evidence_type: IEA
original_reference_id: GO_REF:0000044
review:
summary: Well-supported localization to basement membrane supported by
UniProt subcellular location vocabulary and experimental studies.
action: ACCEPT
reason: SPARC is well-documented to localize in or around basement
membranes, where it modulates ECM assembly and cell-matrix interactions.
UniProt annotation states "In or around the basement membrane" based on
multiple experimental studies.
- term:
id: GO:0005615
label: extracellular space
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: Duplicate annotation consistent with IBA evidence.
action: ACCEPT
reason: This IEA annotation from InterPro is consistent with experimental
evidence and can be retained.
- term:
id: GO:0046872
label: metal ion binding
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: Overly generic term when specific calcium ion binding is
documented.
action: MODIFY
reason: SPARC specifically binds calcium ions (GO:0005509), which is already
well-annotated. The generic "metal ion binding" term is less informative
than the specific calcium ion binding annotations. SPARC also binds copper
ions, but the primary and most extensively studied metal binding activity
is calcium.
proposed_replacement_terms:
- id: GO:0005509
label: calcium ion binding
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:18808384
review:
summary: Non-informative generic annotation for interaction with bacterial
protein FafA from Finegoldia magna.
action: REMOVE
reason: The generic "protein binding" term provides no functional insight.
This study identifies SPARC as a binding partner for a bacterial adhesin
but does not inform our understanding of SPARC's core molecular functions.
This appears to be an opportunistic interaction during bacterial infection
rather than a core biological activity.
supported_by:
- reference_id: PMID:18808384
supporting_text: Epub 2008 Sep 18. Identification of a novel protein
promoting the colonization and survival of Finegoldia magna, a bacterial
commensal and opportunistic pathogen.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:19011090
review:
summary: Non-informative generic annotation from collagen binding study.
action: REMOVE
reason: This study demonstrated collagen binding (already captured by
GO:0005518), not a distinct protein binding function. The generic "protein
binding" term adds no additional functional information beyond the
specific collagen binding annotations.
supported_by:
- reference_id: PMID:19011090
supporting_text: Structural basis of sequence-specific collagen
recognition by SPARC.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:20926826
review:
summary: Non-informative generic annotation for interaction with myocilin.
action: REMOVE
reason: While the SPARC-myocilin interaction may be relevant in glaucoma
pathology, the generic "protein binding" term provides no functional
insight. The study does not establish this as a core molecular function of
SPARC.
supported_by:
- reference_id: PMID:20926826
supporting_text: 'Print 2011 Jan. Interaction of recombinant myocilin with the
matricellular protein SPARC: functional implications.'
- term:
id: GO:0005201
label: extracellular matrix structural constituent
evidence_type: RCA
original_reference_id: PMID:28327460
review:
summary: Mischaracterization of SPARC as a structural ECM component.
action: REMOVE
reason: SPARC is definitively a matricellular protein, not a structural ECM
component. Matricellular proteins modulate cell-matrix interactions and
ECM assembly but do not themselves provide structural support. This
annotation fundamentally misrepresents SPARC biology. The correct
molecular function is as a regulatory/modulating protein, not as a
structural constituent.
supported_by:
- reference_id: PMID:28327460
supporting_text: Epub 2017 Mar 7. Comprehensive proteomic characterization
of stem cell-derived extracellular matrices.
- term:
id: GO:0031012
label: extracellular matrix
evidence_type: HDA
original_reference_id: PMID:28327460
review:
summary: High-throughput proteomic identification of SPARC in ECM consistent
with core localization.
action: ACCEPT
reason: This HDA annotation from a proteomic study of stem cell-derived ECM
is consistent with the well-established ECM localization of SPARC.
supported_by:
- reference_id: PMID:28327460
supporting_text: Epub 2017 Mar 7. Comprehensive proteomic characterization
of stem cell-derived extracellular matrices.
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9612277
review:
summary: Plasma membrane localization is supported by experimental evidence,
though this specific citation may be from a pathway context.
action: ACCEPT
reason: While this Reactome annotation may have been derived from a pathway
context, SPARC plasma membrane localization is supported by direct
experimental evidence (IDA) showing localization to alpha-granule
membranes, which are plasma membrane-derived.
- term:
id: GO:0005576
label: extracellular region
evidence_type: HDA
original_reference_id: PMID:27068509
review:
summary: High-throughput proteomic identification in varicose vein ECM.
action: ACCEPT
reason: This proteomic study of ECM remodeling in varicose veins identified
SPARC, consistent with its core extracellular/ECM localization.
supported_by:
- reference_id: PMID:27068509
supporting_text: 'Apr 11. Extracellular matrix remodelling in response to venous
hypertension: proteomics of human varicose veins.'
- term:
id: GO:0001937
label: negative regulation of endothelial cell proliferation
evidence_type: IDA
original_reference_id: PMID:12867428
review:
summary: Direct experimental evidence for SPARC peptides inhibiting
endothelial cell proliferation.
action: ACCEPT
reason: This study demonstrated that MMP-3 cleavage of SPARC produces
peptides (Z-2 and Z-3) that inhibit endothelial cell proliferation in a
concentration-dependent manner. This anti-proliferative effect on
endothelial cells is part of SPARC's anti-angiogenic activities and
represents a core biological function.
supported_by:
- reference_id: PMID:12867428
supporting_text: "In contrast, peptides Z-2 (6.1 kDa, containing Ca2+-binding
EF hand-1) and Z-3 (2.2 kDa, containing neither Cu2+-binding motifs nor EF
hands), inhibited cell proliferation in a concentration-dependent manner and
exhibited no effects on vessel growth in the CAM."
- term:
id: GO:0005518
label: collagen binding
evidence_type: IDA
original_reference_id: PMID:9501084
review:
summary: Crystal structure and mutagenesis study definitively mapping the
collagen-binding epitope in SPARC with sequence-specific recognition.
action: ACCEPT
reason: This is a definitive structural and functional study showing SPARC
binds collagens I and IV with sequence-specific recognition of the GVMGFO
motif. Five residues (R149, N156, L242, M245, E246) were identified as
crucial for collagen binding. This represents a core molecular function of
SPARC.
supported_by:
- reference_id: PMID:9501084
supporting_text: "Five residues were crucial for binding, R149 and N156 in helix
alphaA, and L242, M245 and E246 in a loop region connecting the two EF hands
of BM-40. These residues are spatially close and form a flat ring of 15 A
diameter which matches the diameter of a triple-helical collagen domain. The
mutations showed similar effects on binding to collagens I and IV, indicating
nearly identical binding sites on both collagens."
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IDA
original_reference_id: PMID:15389586
review:
summary: Experimental evidence for intracellular SPARC localization in
cycling urothelial cells.
action: KEEP_AS_NON_CORE
reason: This study demonstrated that cycling urothelial cells sequester
SPARC within cytoplasm and nuclei, while differentiated cells show apical
membrane localization. While this is legitimate experimental evidence,
cytoplasmic localization represents trafficking/biosynthetic localization
rather than the functional location where SPARC exerts its core
matricellular activities. SPARC is a secreted protein with an N-terminal
signal peptide.
supported_by:
- reference_id: PMID:15389586
supporting_text: "In contrast, the basal layer of transitional epithelium in
vivo and cycling cells in vitro did not exhibit this apical staining pattern,
but instead sequestered the SPARC polypeptide within urothelial cytoplasm
and/or nuclei, as revealed by immunohistochemical analysis."
- term:
id: GO:0009986
label: cell surface
evidence_type: IDA
original_reference_id: PMID:15389586
review:
summary: Experimental evidence for SPARC localization at apical plasma
membrane of differentiated urothelial cells.
action: ACCEPT
reason: This study showed polarized localization of SPARC to apical plasma
membranes of suprabasal/intermediate urothelial cells. Cell surface
localization is relevant for SPARC's counter-adhesive function and
interaction with cell surface receptors, though the primary functional
location is the extracellular matrix.
supported_by:
- reference_id: PMID:15389586
supporting_text: "Through the use of a monoclonal antibody that recognizes this
epitope, transitional epithelium was found to restrict expression of SPARC
to the suprabasal and intermediate layer. Such intracellular expression was
defined by immunoreactive signals that localized to the apical plasma membranes
of suprabasal and intermediate cells."
- term:
id: GO:0010595
label: positive regulation of endothelial cell migration
evidence_type: IDA
original_reference_id: PMID:12867428
review:
summary: SPARC-derived peptides stimulate endothelial cell migration in
collagen gels.
action: ACCEPT
reason: This study showed that MMP-3-generated SPARC peptides Z-2 and Z-3
stimulated endothelial cell migration in collagen gels, demonstrating a
pro-migratory effect. This represents part of SPARC's complex,
context-dependent regulation of angiogenesis where different fragments
have distinct activities.
supported_by:
- reference_id: PMID:12867428
supporting_text: "Reciprocal results were obtained in a migration assay in native
collagen gels: peptide Z-1 was ineffective over a range of concentrations,
whereas Z-2 or Z-3 stimulated cell migration."
- term:
id: GO:0016363
label: nuclear matrix
evidence_type: IDA
original_reference_id: PMID:15389586
review:
summary: Experimental evidence for SPARC in nuclear matrix, colocalized with
Ki-67.
action: KEEP_AS_NON_CORE
reason: The study demonstrated SPARC presence in the nuclear matrix where it
colocalized with Ki-67 antigen in cycling urothelial cells. However, this
represents an atypical localization for a secreted matricellular protein.
Nuclear localization may reflect biosynthetic/trafficking processes rather
than core function. The functional significance remains unclear.
supported_by:
- reference_id: PMID:15389586
supporting_text: "Elution of soluble proteins and DNA from urothelial cells
revealed the presence of SPARC within the nuclear matrix--and that SPARC colocalized
with the nuclear matrix Ki-67 antigen."
- term:
id: GO:0016525
label: negative regulation of angiogenesis
evidence_type: IDA
original_reference_id: PMID:12867428
review:
summary: SPARC-derived peptides inhibit angiogenesis in vivo.
action: ACCEPT
reason: This study demonstrated that certain SPARC peptides (Z-2, Z-3)
generated by MMP-3 cleavage inhibit angiogenesis, having no effect on
vessel growth in the chick chorioallantoic membrane assay. This
anti-angiogenic activity represents a core biological function of SPARC,
though the protein shows context-dependent pro- and anti-angiogenic
effects.
supported_by:
- reference_id: PMID:12867428
supporting_text: "In contrast, peptides Z-2 (6.1 kDa, containing Ca2+-binding
EF hand-1) and Z-3 (2.2 kDa, containing neither Cu2+-binding motifs nor EF
hands), inhibited cell proliferation in a concentration-dependent manner and
exhibited no effects on vessel growth in the CAM."
- term:
id: GO:0022604
label: regulation of cell morphogenesis
evidence_type: IDA
original_reference_id: PMID:15389586
review:
summary: SPARC inhibits cell spreading and promotes cell rounding in
urothelial cells.
action: ACCEPT
reason: This study demonstrated that recombinant SPARC inhibits spreading of
freshly plated urothelial cells in a concentration- and time-dependent
manner (rounding assay). This counter-adhesive effect on cell morphology
is a core biological function of SPARC as a matricellular protein that
disrupts focal adhesions and regulates cell shape.
supported_by:
- reference_id: PMID:15389586
supporting_text: "rSPARC activity was demonstrated and quantified with a rounding
assay whereby the spreading of freshly plated cells was inhibited by recombinant
SPARC in a concentration- and time-dependent manner. Inhibition of spreading
was observed in urothelial cells derived from endoderm (bladder) and mesoderm
(ureter) germ layers."
- term:
id: GO:0005509
label: calcium ion binding
evidence_type: IDA
original_reference_id: PMID:7034958
review:
summary: Direct experimental demonstration of calcium binding by osteonectin
in the seminal 1981 study.
action: ACCEPT
reason: This is the foundational experimental evidence for SPARC calcium
binding activity. The study demonstrated that osteonectin binds free
calcium ions and showed this is a core molecular function.
supported_by:
- reference_id: PMID:7034958
supporting_text: "Osteonectin is a 32,000 dalton bone-specific protein that
binds selectively to both hydroxyapatite and collagen. When osteonectin is
bound to insolubilized type I collagen, the resultant complex binds synthetic
apatite crystals and free calcium ions."
- term:
id: GO:0005518
label: collagen binding
evidence_type: IDA
original_reference_id: PMID:7034958
review:
summary: Foundational experimental evidence demonstrating SPARC binds
selectively to collagen type I.
action: ACCEPT
reason: This 1981 study provided the first experimental demonstration that
osteonectin/SPARC binds selectively to type I collagen, establishing
collagen binding as a core molecular function. When bound to collagen, the
complex also binds calcium and nucleates mineral deposition.
supported_by:
- reference_id: PMID:7034958
supporting_text: "Osteonectin is a 32,000 dalton bone-specific protein that
binds selectively to both hydroxyapatite and collagen. When osteonectin is
bound to insolubilized type I collagen, the resultant complex binds synthetic
apatite crystals and free calcium ions."
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IDA
original_reference_id: PMID:11856645
review:
summary: Cytoplasmic localization during biosynthesis in developing teeth.
action: KEEP_AS_NON_CORE
reason: This study on developing human teeth detected osteonectin/SPARC in
cytoplasm, consistent with biosynthetic/secretory pathway localization. As
a secreted protein, SPARC transits through the cytoplasm but this is not
its functional location.
supported_by:
- reference_id: PMID:11856645
supporting_text: Investigation of osteocalcin, osteonectin, and dentin
sialophosphoprotein in developing human teeth.
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IDA
original_reference_id: PMID:1737102
negated: true
review:
summary: PMID:1737102 localized platelet osteonectin to alpha-granule
membranes rather than cytoplasm.
action: ACCEPT
reason: The study used immunogold labeling to localize osteonectin to the
internal face of alpha-granule membranes, supporting a NOT cytoplasm
annotation for this PMID.
supported_by:
- reference_id: PMID:1737102
supporting_text: Localization of platelet osteonectin at the internal face
of the alpha-granule membranes in platelets and megakaryocytes.
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IDA
original_reference_id: PMID:3400777
review:
summary: Cytoplasmic staining in decidua and carcinoma tissues.
action: KEEP_AS_NON_CORE
reason: This immunolocalization study in decidua and carcinoma showed
cytoplasmic staining, consistent with biosynthetic/secretory pathway
localization for this secreted ECM protein. Not the primary functional
location.
supported_by:
- reference_id: PMID:3400777
supporting_text: Osteonectin/SPARC/BM-40 in human decidua and carcinoma,
tissues characterized by de novo formation of basement membrane.
- term:
id: GO:0005739
label: mitochondrion
evidence_type: IDA
original_reference_id: PMID:1737102
negated: true
review:
summary: PMID:1737102 did not detect mitochondrial localization of platelet
osteonectin.
action: ACCEPT
reason: This PMID reports alpha-granule membrane localization and supports a
NOT mitochondrion annotation.
supported_by:
- reference_id: PMID:1737102
supporting_text: Localization of platelet osteonectin at the internal face
of the alpha-granule membranes in platelets and megakaryocytes.
- term:
id: GO:0005886
label: plasma membrane
evidence_type: IDA
original_reference_id: PMID:1737102
negated: true
review:
summary: PMID:1737102 localized osteonectin to alpha-granule membranes and
did not report plasma membrane localization in resting platelets.
action: ACCEPT
reason: The abstract indicates internal alpha-granule membrane localization
and a redistribution to the surface upon activation, so GOA captures this
PMID as NOT plasma membrane.
supported_by:
- reference_id: PMID:1737102
supporting_text: Localization of platelet osteonectin at the internal face
of the alpha-granule membranes in platelets and megakaryocytes.
- term:
id: GO:0009986
label: cell surface
evidence_type: IDA
original_reference_id: PMID:3400777
review:
summary: Cell surface localization in decidua and carcinoma tissues.
action: ACCEPT
reason: This immunolocalization study detected SPARC at cell surfaces in
decidua and carcinoma. Cell surface localization is consistent with
SPARC's counter-adhesive function and its ability to interact with cell
surface receptors while also being deposited into the ECM.
supported_by:
- reference_id: PMID:3400777
supporting_text: Osteonectin/SPARC/BM-40 in human decidua and carcinoma,
tissues characterized by de novo formation of basement membrane.
- term:
id: GO:0031091
label: platelet alpha granule
evidence_type: IDA
original_reference_id: PMID:1737102
review:
summary: Well-established localization of SPARC in platelet alpha granules.
action: ACCEPT
reason: SPARC is a well-documented component of platelet alpha granules,
where it is stored and released upon platelet activation. This is an
established biological function of SPARC in hemostasis and wound healing.
The study specifically localized osteonectin to the internal face of
alpha-granule membranes.
supported_by:
- reference_id: PMID:1737102
supporting_text: Localization of platelet osteonectin at the internal face
of the alpha-granule membranes in platelets and megakaryocytes.
- term:
id: GO:0031092
label: platelet alpha granule membrane
evidence_type: IDA
original_reference_id: PMID:1737102
review:
summary: Specific localization to the internal face of platelet alpha
granule membranes.
action: ACCEPT
reason: This study specifically demonstrated SPARC localization at the
internal face of alpha-granule membranes in platelets and megakaryocytes,
representing a more specific localization than just the alpha granule
lumen. This is well-supported experimental evidence.
supported_by:
- reference_id: PMID:1737102
supporting_text: Localization of platelet osteonectin at the internal face
of the alpha-granule membranes in platelets and megakaryocytes.
- term:
id: GO:0031093
label: platelet alpha granule lumen
evidence_type: TAS
original_reference_id: Reactome:R-HSA-481007
review:
summary: Reactome pathway annotation for SPARC in platelet degranulation.
action: ACCEPT
reason: This Reactome annotation captures SPARC as a component released
during platelet alpha granule exocytosis. This is consistent with
experimental evidence showing SPARC in platelet alpha granules.
- term:
id: GO:0071682
label: endocytic vesicle lumen
evidence_type: TAS
original_reference_id: Reactome:R-HSA-2247513
review:
summary: Reactome annotation for SPARC uptake via STAB1-mediated
endocytosis.
action: KEEP_AS_NON_CORE
reason: This Reactome pathway describes STAB1 (stabilin-1/FEEL-1)-mediated
endocytosis of SPARC. While this represents a clearance mechanism for
extracellular SPARC, endocytic vesicle localization is not a core
functional location but rather represents protein turnover/degradation.
- term:
id: GO:0005576
label: extracellular region
evidence_type: TAS
original_reference_id: Reactome:R-HSA-2197770
review:
summary: Reactome annotation for SPARC as STAB1 ligand.
action: ACCEPT
reason: This Reactome pathway describes SPARC binding to STAB1 receptor,
consistent with SPARC's extracellular localization where it can interact
with cell surface receptors.
- term:
id: GO:0005576
label: extracellular region
evidence_type: TAS
original_reference_id: Reactome:R-HSA-2247513
review:
summary: Reactome annotation for STAB1-mediated endocytosis of extracellular
SPARC.
action: ACCEPT
reason: Consistent with SPARC's extracellular localization prior to
receptor-mediated endocytosis.
- term:
id: GO:0005576
label: extracellular region
evidence_type: TAS
original_reference_id: Reactome:R-HSA-2424243
review:
summary: Reactome annotation for SPARC binding to collagen, hydroxylapatite,
and Ca2+.
action: ACCEPT
reason: This Reactome pathway captures SPARC's core molecular interactions
in the extracellular matrix, consistent with its matricellular function.
- term:
id: GO:0005576
label: extracellular region
evidence_type: TAS
original_reference_id: Reactome:R-HSA-481007
review:
summary: Reactome annotation for SPARC release during platelet
degranulation.
action: ACCEPT
reason: Consistent with SPARC being released into the extracellular region
during platelet alpha granule exocytosis.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:3402455
review:
summary: Non-informative generic annotation for thrombospondin binding.
action: REMOVE
reason: While SPARC forms complexes with thrombospondin in the ECM, the
generic "protein binding" term provides no functional insight. The
biological significance of this interaction is unclear and does not
represent a core molecular function of SPARC.
supported_by:
- reference_id: PMID:3402455
supporting_text: Complex formation of human thrombospondin with
osteonectin.
- term:
id: GO:0005576
label: extracellular region
evidence_type: NAS
original_reference_id: PMID:14718574
review:
summary: Non-traceable author statement identifying SPARC in human plasma
proteome.
action: ACCEPT
reason: SPARC is a known component of the human plasma proteome, consistent
with its secreted nature and presence in blood from platelet alpha
granules. This represents extracellular localization.
supported_by:
- reference_id: PMID:14718574
supporting_text: 'Epub 2004 Jan 12. The human plasma proteome: a nonredundant
list developed by combination of four separate sources.'
- term:
id: GO:0050839
label: cell adhesion molecule binding
evidence_type: NAS
review:
summary: Added to align core_functions with existing annotations.
action: NEW
reason: Core function term not present in existing_annotations.
supported_by:
- reference_id: PMID:15389586
supporting_text: "rSPARC activity was demonstrated and quantified with a rounding
assay whereby the spreading of freshly plated cells was inhibited by recombinant
SPARC in a concentration- and time-dependent manner."
core_functions:
- description: SPARC binds to collagens I, IV, and V with sequence-specific
recognition of the GVMGFO motif through five critical residues (R149, N156,
L242, M245, E246) that form the collagen-binding epitope. This high-affinity
interaction is central to SPARC's role in ECM organization and bone
mineralization.
molecular_function:
id: GO:0005518
label: collagen binding
locations:
- id: GO:0031012
label: extracellular matrix
supported_by:
- reference_id: PMID:9501084
supporting_text: "Five residues were crucial for binding, R149 and N156 in helix
alphaA, and L242, M245 and E246 in a loop region connecting the two EF hands
of BM-40. These residues are spatially close and form a flat ring of 15 A diameter
which matches the diameter of a triple-helical collagen domain."
- reference_id: PMID:19011090
supporting_text: "SPARC recognizes the GVMGFO motifs of the middle and trailing
collagen chains, burying a total of 720 A(2) of solvent-accessible collagen
surface."
- description: SPARC binds 8-10 calcium ions per molecule through two distinct
mechanisms - low-affinity binding via the acidic N-terminal domain (5-8
Ca2+) and high-affinity binding via the C-terminal EF-hand domain. Calcium
binding is essential for protein structure, stability, and collagen
interaction.
molecular_function:
id: GO:0005509
label: calcium ion binding
locations:
- id: GO:0031012
label: extracellular matrix
supported_by:
- reference_id: PMID:7034958
supporting_text: "Osteonectin is a 32,000 dalton bone-specific protein that binds
selectively to both hydroxyapatite and collagen. When osteonectin is bound to
insolubilized type I collagen, the resultant complex binds synthetic apatite
crystals and free calcium ions."
- description: SPARC functions as a matricellular counter-adhesive protein that
disrupts focal adhesions, promotes cell rounding/deadhesion, and inhibits
cell spreading. This activity regulates cell-matrix interactions and cell
morphology during tissue remodeling, development, and wound healing.
molecular_function:
id: GO:0050839
label: cell adhesion molecule binding
directly_involved_in:
- id: GO:0022604
label: regulation of cell morphogenesis
locations:
- id: GO:0005576
label: extracellular region
supported_by:
- reference_id: PMID:15389586
supporting_text: "rSPARC activity was demonstrated and quantified with a rounding
assay whereby the spreading of freshly plated cells was inhibited by recombinant
SPARC in a concentration- and time-dependent manner."
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with
GO terms.
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000043
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
findings: []
- id: GO_REF:0000044
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular
Location vocabulary mapping, accompanied by conservative changes to GO terms
applied by UniProt.
findings: []
- id: PMID:11856645
title: Investigation of osteocalcin, osteonectin, and dentin
sialophosphoprotein in developing human teeth.
findings: []
- id: PMID:12867428
title: Cleavage of the matricellular protein SPARC by matrix metalloproteinase
3 produces polypeptides that influence angiogenesis.
findings: []
- id: PMID:14718574
title: 'The human plasma proteome: a nonredundant list developed by combination
of four separate sources.'
findings: []
- id: PMID:15389586
title: Spreading of embryologically distinct urothelial cells is inhibited by
SPARC.
findings: []
- id: PMID:1737102
title: Localization of platelet osteonectin at the internal face of the
alpha-granule membranes in platelets and megakaryocytes.
findings: []
- id: PMID:18808384
title: Identification of a novel protein promoting the colonization and
survival of Finegoldia magna, a bacterial commensal and opportunistic
pathogen.
findings: []
- id: PMID:19011090
title: Structural basis of sequence-specific collagen recognition by SPARC.
findings: []
- id: PMID:20926826
title: 'Interaction of recombinant myocilin with the matricellular protein SPARC:
functional implications.'
findings: []
- id: PMID:27068509
title: 'Extracellular matrix remodelling in response to venous hypertension: proteomics
of human varicose veins.'
findings: []
- id: PMID:28327460
title: Comprehensive proteomic characterization of stem cell-derived
extracellular matrices.
findings: []
- id: PMID:3400777
title: Osteonectin/SPARC/BM-40 in human decidua and carcinoma, tissues
characterized by de novo formation of basement membrane.
findings: []
- id: PMID:3402455
title: Complex formation of human thrombospondin with osteonectin.
findings: []
- id: PMID:7034958
title: Osteonectin, a bone-specific protein linking mineral to collagen.
findings: []
- id: PMID:9501084
title: Crystal structure and mapping by site-directed mutagenesis of the
collagen-binding epitope of an activated form of BM-40/SPARC/osteonectin.
findings: []
- id: Reactome:R-HSA-2197770
title: STAB1 (FEEL-1) binds ligands
findings: []
- id: Reactome:R-HSA-2247513
title: STAB1:ligand is endocytosed
findings: []
- id: Reactome:R-HSA-2424243
title: SPARC binds Collagen type I fibril, hydroxylapatite and Ca2+
findings: []
- id: Reactome:R-HSA-481007
title: Exocytosis of platelet alpha granule contents
findings: []
- id: Reactome:R-HSA-9612277
title: SPARC gene transcription is stimulated by ERBB4s80
findings: []